<DOC>
	<DOCNO>NCT01150747</DOCNO>
	<brief_summary>The primary objective prospectively follow 200 woman risk cervicitis determine chlamydia-specific cellular response correlate protection incident infection . The hypothesis positive IFN-y response peripheral CD4+ T cell respond stimulation HSP60 significantly associate protection incident C. trachomatis infection .</brief_summary>
	<brief_title>Chlamydia Trachomatis Immunology Vaccinology Study</brief_title>
	<detailed_description>A total 200 woman high risk cervicitis prospectively follow correlation chlamydia-specific cellular response protection incident infection . At enrollment participant undergo history physical examination ; blood draw ; pelvic examination include collection vaginal cervical sample , STD test endometrial biopsy . Participants follow visit conduct 1 , 4 , 8 12 month follow enrollment . At follow-up visit , participant undergo repeat history physical , blood draw pelvic examination include collection vaginal cervical sample STD test . The study design allow comprehensive identification antigen-specific cell mediate immune response strongly associate protection C. trachomatis infection . The primary objective prospectively follow 200 woman risk cervicitis determine chlamydia-specific cellular response correlate protection incident infection .</detailed_description>
	<mesh_term>Chlamydia Infections</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<criteria>Inclusion Criteria 1 . Women 1535 year age . Note : Minors must write informed consent parent/legal guardian participate . 2 . At least one following : 1 . Current , untreated endocervical C. trachomatis infection . 2 . Mucopurulent cervicitis : define presence yellow green endocervical mucopurulent discharge and/ easily induce endocervical bleeding ( bleed first swab place endocervix ) . 3 . Sexual contact male partner ( regardless condom use ) recently diagnose ( within past 3 month ) C. trachomatis and/or nongonococcal urethritis . 1 . Pregnant nursing baby . Note : urine pregnancy test do enrollment . Result must negative participate study . 2 . Gynecologic surgery surgical abortion precede 2 month enrollment . 3 . Allergy study medication and/or derivative ( cephalosporin , azithromycin , erythromycin , macrolide ketolide antibiotic ) Type 1 hypersensitivity allergic reaction penicillin . 4 . Systemic vaginal antibiotic therapy precede 7 day enrollment . 5 . Prior hysterectomy . 6 . Menopause . 7 . Any condition , opinion investigator would interfere participant 's safety study outcome . 8 . Participation study involve investigational product past 30 day anticipation participation study use investigational product next 30 day . 9 . Previous participation study .</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>